Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin in Post-stroke Upper Limb Spasticity
NCT00432666Phase 3Completed
- Sponsor
- Merz
- Start
- Jun 2006
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in spasticity comparing IncobotulinumtoxinA with Placebo (2 arms). Primary endpoint: Number of Participants With Reduction of at Least 1 Point at Week 4 Compared to Baseline in Ashworth Score in Wrist Flexors. Started Jun 2006; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT00432666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432666.